A detailed history of Pegasus Partners Ltd. transactions in Veru Inc. stock. As of the latest transaction made, Pegasus Partners Ltd. holds 12,067 shares of VERU stock, worth $8,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,067
Previous 12,067 -0.0%
Holding current value
$8,205
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$4.55 - $6.41 $27,450 - $38,671
-6,033 Reduced 33.33%
12,067 $58,000
Q1 2021

May 14, 2021

BUY
$8.05 - $20.78 $145,705 - $376,118
18,100 New
18,100 $195,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $54.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Pegasus Partners Ltd. Portfolio

Follow Pegasus Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.